Patents matching “treatment”

US 11826321

Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions

TONIX PHARMA LIMITED · Granted Nov 28, 2023 · Expires Nov 23, 2043

US 11826339

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

US 11820982

Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitors

REGENERON PHARMACEUTICALS, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

US 11819573

Treatment of hip pain with sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

US 11819572

Treatment of pain by administration of sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

US 11819523

Compositions and methods for C. difficile treatment

Regents of the University of Minnesota · Granted Nov 21, 2023 · Expires Nov 16, 2043

US 11814622

OPA1 antisense oligomers for treatment of conditions and diseases

STOKE THERAPEUTICS, INC. · Granted Nov 14, 2023 · Expires Nov 9, 2043

US 11813357

Treatment of hip pain with sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. · Granted Nov 14, 2023 · Expires Nov 9, 2043

US 11813282

Injectable scaffold for treatment of intracranial aneurysms and related technology

Covidien LP · Granted Nov 14, 2023 · Expires Nov 9, 2043

US 11806406

Virus-like particle conjugates for diagnosis and treatment of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2023 · Expires Nov 2, 2043

US 11806334

Non-sedating dexmedetomidine treatment regimens

BioXcel Therapeutics, Inc. · Granted Nov 7, 2023 · Expires Nov 2, 2043

US 11806336

Methods and compositions for treatment of epileptic disorders

OVID THERAPEUTICS INC. · Granted Nov 7, 2023 · Expires Nov 2, 2043

US 11802131

Glutarimides for medical treatment

C4 THERAPEUTICS, INC. · Granted Oct 31, 2023 · Expires Oct 26, 2043

US 11801288

Cancer vaccines and methods of treatment using the same

Inovio Pharmaceuticals, Inc. · Granted Oct 31, 2023 · Expires Oct 26, 2043

US 11801313

Materials and methods for treatment of pain related disorders

Vertex Pharmaceuticals Incorporated · Granted Oct 31, 2023 · Expires Oct 26, 2043

US 11801265

Preparation method of NK cells and use thereof in the treatment of cancer

SINO UNITED (BEIJING) BIOMEDICAL TECHNOLOGY CO., LTD. · Granted Oct 31, 2023 · Expires Oct 26, 2043

US 11795457

Compositions and methods for treatment of Friedreich's Ataxia

The Board of Regents of the University of Texas System · Granted Oct 24, 2023 · Expires Oct 19, 2043

US 11795216

Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics

Takeda Pharmaceutical Company Limited · Granted Oct 24, 2023 · Expires Oct 19, 2043

US 11786601

Pegylated capsule-degrading enzyme for the treatment of anthrax

The Government of the United States of America, as represented by the Secretary of the Navy · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11786517

Methods of treatment using a JAK inhibitor compound

Theravance Biopharma R&D IP, LLC · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11786602

ASH1L degraders and methods of treatment therewith

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11786502

Method of treatment

VANDA PHARMACEUTICALS INC. · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11786508

Use of sublingual dexmedetomidine for the treatment of agitation

BioXcel Therapeutics, Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11779565

Small organic molecules for use in the treatment of neuroinflammatory disorders

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Oct 10, 2023 · Expires Oct 5, 2043